Clinical trial · Interventional
Nutritional Support for Patients Operated for Malignant Tumors in HPD Zone
Nutritional Support for Patients Operated on for Malignant Tumors of the Hepatico-pancreato-duodenal (HPD) Zone in the Early Postoperative Period
NCT06397430CI-TRIAL-00076682completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
A comprehensive comparative analysis of the effectiveness of isolated enteral, isolated parenteral and mixed type of nutritional support in the early postoperative period in patients after operations performed on the malignant neoplasms of hepatico-pancreatico-duodenal zone.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hepato-Biliary Neoplasm | — | UNRESOLVED | — |
| Nutritional Support | — | UNRESOLVED | — |
| Postoperative | — | UNRESOLVED | — |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| enteral nutrition supplements | Dietary Supplement | — | UNRESOLVED |
| mixed nutrition supplements | Dietary Supplement | — | UNRESOLVED |
| parenteral nutrition supplements | Dietary Supplement | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- type
- EXPERIMENTAL
- label
- Arm 1 - enteral nutrition
- description
- patients receiving enteral nutrition (EN) after surgery
- interventionNames
- Dietary Supplement: enteral nutrition supplements
- type
- EXPERIMENTAL
- label
- Arm 2 - parenteral nutrition
- description
- patients receiving parenteral nutrition (PN)
- interventionNames
- Dietary Supplement: parenteral nutrition supplements
- type
- EXPERIMENTAL
- label
- Arm 3 - mixed nutrition
- description
- patients receiving mixed nutrition (MF)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 20 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: female and male patients in age of 20-75 with malignant tumors of the hepato-pancreato-duodenal zone who have undergone any of the following operations: 1. resection of various segments of the liver; 2. hemihepatectomy; 3. transhepatic drainage of the right and left hepatic duct; 4. bypass gastroenteroanastomosis or cholecystoenteroanastomosis with interintestinal enteroenteroanastomosis according to Brown; 5. gastro-pancreatoduodenal resection; 6. corporecaudal resection of the pancreas with splenectomy. Exclusion Criteria: * patients in age of up to 20 and older than 75 * pregnant and breastfeeding women
References
Publications (0)
Data not yet available
No reference posted for this study.